Doctor Ke Xu
Shanghai Chest Hospital, Shanghai (China)
PEAR1 rs12041331 polymorphisms and the risk of adverse cardiovascular outcomes in patients with acute coronary syndrome and/or percutaneous coronary intervention: a systematic review and meta-analysis
Event: ESC Congress 2020
Topic: Pharmacogenetics
Session: Pharmacology and Pharmacotherapy ePosters
Genetic polymorphisms and cardiovascular outcomes in Chinese patients undergoing PCI and treated with clopidogrel and aspirin
Event: ESC Congress 2020
Topic: Pharmacogenetics
Session: Pharmacology and Pharmacotherapy ePosters
Association of CYP2C19*2 and PEAR1 gene variant with platelet reactivity and clinical outcomes in patients undergoing stenting and treated with aspirin and clopidogrel
Event: ESC Congress 2018
Topic: Pharmacogenetics
Session: Pharmacogenetics - New sights on the horizon
PEAR1 rs12041331 polymorphisms and the risk of adverse cardiovascular outcomes in patients with acute coronary syndrome and/or percutaneous coronary intervention: a systematic review and meta-analysis
Event: ESC Asia with APSC & AFC 2020
Topic: Pharmacogenetics
Session: Abstract Programme
ESC 365 is supported by
